Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Could Amgen's Heart Disease Candidate Generate Billions in Sales?
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
Submitted by
admin
on December 11, 2022 - 1:26pm
Source:
Motley Fool
News Tags:
Amgen
heart disease
olpasiran
Headline:
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
snippet:
If approved, olpasiran could seize patient share in a large market.
The drug’s annual sales potential could surpass $1 billion.
Amgen’s premium valuation is arguably justified
Do Not Allow Advertisers to Use My Personal information
